Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2014 08:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Present at Stifel 2014 Healthcare Conference

PALO ALTO, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
November 04, 2014 16:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Announce Third Quarter 2014 Financial Results

PALO ALTO, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
September 29, 2014 09:00 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Present at 13th Annual BIO Investor Forum

PALO ALTO, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
September 18, 2014 16:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Announces Appointment of Steven P. James to Board

PALO ALTO, Calif., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
August 11, 2014 16:03 ET | Source: Ocera Therapeutics, Inc.

Ocera Announces Appointment of Rajiv Patni, M.D. as Chief Development Officer

PALO ALTO, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
August 11, 2014 16:02 ET | Source: Ocera Therapeutics, Inc.

Ocera Reports Second Quarter 2014 Financial Results

PALO ALTO, Calif., Aug. 11, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today...
July 31, 2014 16:05 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Announce Second Quarter Financial Results

PALO ALTO, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced...
July 10, 2014 08:33 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Raises $25.2 Million in Public Offering

PALO ALTO, Calif., July 10, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) ("Ocera") today announced that it has priced an underwritten public offering of 4,200,000 shares of its common...
July 09, 2014 16:01 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Announces Proposed Public Offering of Common Stock

PALO ALTO, Calif., July 9, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX) ("Ocera" or "the Company") today announced that it intends to offer and sell, subject to market and other...
June 17, 2014 08:00 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics to Present at the JMP Securities Healthcare Conference 2014

PALO ALTO, Calif., June 17, 2014 (GLOBE NEWSWIRE) -- Ocera Therapeutics (Nasdaq:OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, announced today...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right